Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial (Q21245063)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial |
scientific article |
Statements
Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial (English)
0 references
Samuel T Henderson
1 reference
Janet L Vogel
1 reference
Linda J Barr
1 reference
Fiona Garvin
1 reference
Julie J Jones
1 reference
Lauren C Costantini
1 reference
2009
0 references
6
0 references
31
0 references
1
0 references
1 reference
1 reference
1 reference
Identifiers
1 reference